SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 69 filers reported holding SAVARA INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104 | -8.8% | 27,320 | -23.2% | 0.00% | – |
| Q2 2023 | $114 | +100.0% | 35,559 | +22.8% | 0.00% | – |
| Q1 2023 | $57 | +26.7% | 28,960 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 28,960 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +28.6% | 28,960 | +27.2% | 0.00% | – |
| Q2 2022 | $35,000 | +20.7% | 22,760 | +4.1% | 0.00% | – |
| Q1 2022 | $29,000 | +38.1% | 21,860 | +26.7% | 0.00% | – |
| Q4 2021 | $21,000 | -12.5% | 17,260 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -17.2% | 17,260 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -27.5% | 17,260 | -9.2% | 0.00% | – |
| Q1 2021 | $40,000 | +185.7% | 19,003 | +61.0% | 0.00% | – |
| Q4 2020 | $14,000 | – | 11,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |